Showing results (1-10 of 120) with videos related to
Sort By:
Pageof 12
Drug Intelligence & Clinical Pharmacy|September 1, 1985
Lidocaine-induced second-degree mobitz type II heart blockD E Hilleman, S M Mohiuddin, C J DestacheJournal of Clinical Pharmacology|April 1, 1991
Influence of mexiletine on the pharmacokinetics of theophylline in healthy volunteersA M Stoysich, S M Mohiuddin, C J Destache, et al.Drug Intelligence & Clinical Pharmacy|July 1, 1988
Comparative bioequivalence and efficacy of two sustained-release procainamide formulations in patients with cardiac arrhythmiasD E Hilleman, A J Patterson, S M Mohiuddin, et al.Journal of Clinical Pharmacology|September 1, 1992
Impact of food on the bioavailability of encainideD E Hilleman, S M Mohiuddin, C J Destache, et al.The Annals of Pharmacotherapy|June 11, 1992
Comparative pharmacodynamics of intravenous lidocaine in patients with acute and chronic ventricular arrhythmiasD E Hilleman, S M Mohiuddin, A N Mooss, et al.American Heart Journal|March 11, 1992
Efficacy and safety of early versus late initiation of warfarin during heparin therapy in acute thromboembolismS M Mohiuddin, D E Hilleman, C J Destache, et al.DICP : the Annals of Pharmacotherapy|December 1, 1991
Changing strategies in the management of chronic congestive heart failureD E Hilleman, S M MohiuddinDICP : the Annals of Pharmacotherapy|March 1, 1991
Pharmacokinetic and tolerance evaluation of actisomide, a new antiarrhythmic agent, in healthy volunteersM A Malesker, S M Mohiuddin, C J Destache, et al.Southern Medical Journal|November 5, 1999
Treatment of asymptomatic myocardial ischemiaA N Mooss, D E Hilleman, S M MohiuddinJournal of Clinical Pharmacology|March 1, 1994
Comparison of fixed-dose transdermal nicotine, tapered-dose transdermal nicotine, and buspirone in smoking cessationD E Hilleman, S M Mohiuddin, M G DelcorePageof 12